1HVH
NONPEPTIDE CYCLIC CYANOGUANIDINES AS HIV PROTEASE INHIBITORS
Experimental procedure
Spacegroup name | P 61 |
Unit cell lengths | 63.220, 63.220, 83.680 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | ? - 1.800 |
R-factor | 0.188 |
Rwork | 0.188 |
Starting model (for MR) | 1hvr |
RMSD bond length | 0.013 |
RMSD bond angle | 2.600 |
Phasing software | X-PLOR |
Refinement software | X-PLOR |
Data quality characteristics
Overall | |
High resolution limit [Å] | 1.800 * |
Rmerge | 0.080 * |
Total number of observations | 69844 * |
Number of reflections | 16515 * |
Completeness [%] | 90.0 * |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | Vapor diffusion, hanging drop * | 18 * |
Crystallization Reagents in Literatures
ID | crystal ID | solution | reagent name | concentration (unit) | details |
1 | 1 | drop | protease | 1 (mg/ml) | |
2 | 1 | drop | acetate | 250 (mM) | |
3 | 1 | drop | ammonium sulfate | 100 (mM) | |
4 | 1 | drop | inhibitor | 5000-fold molar excess over the Ki value of the inhibitor |